FDA NDC Directory · JSON-LD · Markdown

Hibsago

NDC 0173-0941 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameBepirovirsen
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryNew Drug Application (innovator) · App NDA221276
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsBEPIROVIRSEN SODIUM (150 mg/mL)
Marketing started20261020
Package count2

External sources

Source: openFDA. Public-domain (CC0).